Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. Cannabis is a really special case.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

SEPTEMBER 16, 2020

Epidiolex is the sole cannabis-derived pharmaceutical that has been approved by the FDA – although it is worth noting that the organization has also approved three synthetic cannabis-related products. Of course, it’s wonderful to see the FDA approve this substance to help those suffering from this rare condition.

Access 98

Access Epilepsy Treatment Conditions 98

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. The availability of medications for patients varies from country to condition. These estimates vary drastically source to source, which reflects what conditions make a patient eligible for a cannabis-based medicine.

Access 89

Access Patients Pharmaceutical Education 89

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients.

Policy 184

Policy Patients Education Legislation 184

FloridaMarijuana.net

JULY 16, 2018

No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Patients that are seeking a natural and alternative medicine to the condition they are facing can register for a medical marijuana card by starting here. I felt free from my ailment. How to start the process?

Marijuana 189

Marijuana Patients Conditions Treatment 189

Cannabis Law Report

JULY 5, 2021

Access Control. Since the ERP is equipped with all of the company’s information, the access to data is controlled. and each user can only access part of the information. The QA department usually defines the user access to be controlled and each user will have his. Some users can have unique privileges to.

Pharmaceutical 111

Pharmaceutical Data Access Business 111

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Legislation is pending, House Bill 350, to expand medical cannabis access. Legislation is pending, House Bill 335, to expand access to medical cannabis in New Hampshire. Click here to email your lawmakers in support of medical access.

Legislation 214

Legislation Decriminalization Hemp Patients 214

MGC Pharma

FEBRUARY 22, 2018

of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels. An increasing number of older people are seeking the treatment for conditions such as inflammatory arthritis, autoimmune disease and chronic pain. namely Australia’s aging population.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

NORML

FEBRUARY 1, 2019

Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of banking access.

Legislation 188

Legislation Decriminalization Access Patients 188

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion 124

Digestion Treatment Conditions Research and Development 124

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. Andrew Turnage, the executive director of the Georgia Access to Medical Cannabis Commission, spoke on this fact.

Oil 98

Oil Patients Access THC 98

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. The live webcast can be accessed here and on the investor page of Marinus’ website. The condition is caused by inherited mutations in either the TSC1 gene or the TSC2 gene. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

SEPTEMBER 2, 2022

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

Canna Law Blog

MARCH 25, 2025

Can businesses cultivate cannabis for pharmaceutical research? The conditions of the relevant licenses and permits. Several proposals aim to: Expand medicinal cannabis access. Pharmacies must: Be registered in Australia. Obtain TGA and state regulatory approvals. Follow strict patient verification and dispensing rules.

Research and Development 86

Research and Development Medicine Compliance Compliance 86

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. Epidyolex has been approved as a treatment option for children as young as two with Lennox-Gastaut syndrome or Dravet syndrome – difficult-to-treat conditions that can cause multiple seizures a day. ” Source BBC: [link].

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 5, 2021

Why does Argentina have the conditions to be an important producer in the cannabis and hemp industry? According to Kulfas, the benefits will include: Health rights: supply of medical cannabis to ensure better access to health. ley cáñamo argentina. Employment: Generation of quality jobs. Exports: Potential foreign exchange generation.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

NORML

FEBRUARY 29, 2020

Legislation is pending, House Bill 268 and House Bill 528, to allow those convicted of simple marijuana possession to petition the court to restrict access to their records. Send a message to your lawmakers in support of access to edibles. Send a message to your lawmakers in opposition to arbitrary THC limits. GA resident? HI resident?

Legislation 160

Legislation Decriminalization Edibles Patients 160

LifeCannMD

MARCH 3, 2025

Today, she maintains a discreet, effective regimen that has reduced her pharmaceutical intake by over half. The childproof containers can be challenging, but the medication itself is accessible.” Initially hesitant due to personal perceptions, Elena discovered marijuana THC edibles that transformed her treatment experience.

Edibles 52

Edibles Marijuana Dispensary Patients 52

SpeedWeed

APRIL 9, 2021

Although this survey is specifically focused on Texas’ medical marijuana program, it also supports other research showing that cannabis can serve as an effective replacement for pharmaceuticals. The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Poland and cannabis. Can you grow your own weed?

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Canna Care Docs

NOVEMBER 4, 2024

Patients dealing with chronic pain from numerous conditions are finding relief in cannabis. Healthcare, tennis player and injured black man or athlete with muscle pain or inflammation after exercise or workout Chronic Pain and Challenges Chronic pain is a long-lasting condition that persists for more than 3-6 months, sometimes lasting years.

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. This can be as simple as taking a picture of a prescription bottle you have been given to treat your condition. What Conditions Qualify for Medical Marijuana Cards in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JANUARY 4, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Unfortunately, this number is expected to increase rapidly with legalized marijuana and access to substances that have five times the THC concentration of regular marijuana,” said Mr. Allen. “We About Anebulo Pharmaceuticals, Inc. and Australia.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

The Cannigma

FEBRUARY 4, 2021

When it comes to cannabis and the struggle for legalization, improving access, and changing hearts and minds, advocates often find themselves up against decades-old myths, misconceptions, and stereotypes that have been delivered from authoritative sources for so long that for many people they supplant the truth. grandbrothers/123rf).

Cannabinoids 145

Cannabinoids THC Blood Pressure Conditions 145

Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. Even though the use of CBD for medicine has the support of the FDA, the methods of extracting CBD and the marketing of CBD products will likely become the subjects of high scrutiny.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

The Cannigma

JUNE 1, 2021

Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Some of the qualifying health conditions include epilepsy, neuropathic pain, chemotherapy side effects, a need for palliative care, and pain linked to multiple sclerosis, according to France24.

Law 112

Law Epilepsy Programs Patients 112

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. info@gl-lg.com ? or 503-488-5424.

Access 52

Access Patients Research and Development Treatment 52